English 
Español 
News
Provisions for the registration, re-registration and changes in the sanitary registry and the importation of pharmaceutical products and medical devices; and for the operation of pharmaceutical establishments
A través del Decreto Supremo Nº 018-2020-SA publicado el 22 de mayo del 2020 en el Diario Oficial “El Peruano”, se dictaron disposiciones referidas al Certificado de Buenas Prácticas de Manufactura y al Certificado de Producto Farmacéutico o Certificado de Libre Comercialización, para la inscripción, reinscripción y cambios en el registro sanitario y la importación, de productos farmacéuticos y dispositivos médicos; así como, otras disposiciones para el funcionamiento de los establecimientos farmacéuticos.
Estas medidas extraordinarias se establecieron en el contexto de la expansión del COVID-19, con la finalidad de asegurar el abastecimiento y suministro de productos farmacéuticos y dispositivos médicos en el mercado peruano.
Source: Official Gazette "El Peruano"
Recent posts
Provisions for the registration, re-registration and changes in the sanitary registry and the importation of pharmaceutical products and medical devices; and for the operation of pharmaceutical establishments
They approve the technical document: "Ethical considerations for health research with human beings"
They approve the "List of documents considered equivalent to the certificate of good manufacturing practices"
Extension of the suspension of the computation of processing periods of Administrative Procedures
The Ministry of Health of Peru approved the Sanitary Directive for the Control and Surveillance of In Vitro Diagnostic Devices: Rapid and Molecular Tests for COVID-19
They form the temporary national research ethics committee for the evaluation and ethical supervision of clinical trials of the covid-19 disease
They form the National Network for Health Technology Assessment (RENETSA) and approve other provisions
Temporary measures are issued to ensure the supply of products necessary for health during the health emergency declared as a consequence of COVID-19
They approve the document called: Technical specification for the manufacture of textile face masks for community use
They publish a law that regulates the use of modeling substances in body treatments for aesthetic purposes and defines said procedure as a medical act
They publish a law that modifies article 34 of the "Law on pharmaceutical products, medical devices and health products"
Exceptional authorization for the import and use of medicines, medical devices or health products with a medical prescription
DIGEMID ordered safety modifications in the pharmaceutical specialties that contain "QUINOLONES and FLUOROQUINOLONES"
They approve the regulation that establishes the classification rules and the essential principles of safety and performance of medical devices
Web application to report the discontinuation of the manufacture or import of medicines or biological products, and their reactivation
DIGEMID updates the list of products that to date are not subject to the granting of sanitary registration
Draft technical document published: manual of good pharmacovigilance practices
DIGEMID statement on the mercury component in medical devices and cosmetic products
DIGEMID statement on nonylphenol and ethoxylated nonylphenol components
DIGEMID ordered safety modifications in the technical data sheet and/or in the insert of the medicines that contain "ondansetron"
